Author
Jia‐Zhuang Xu
Recent research
- Materials & Energy
Abstract Fe3O4, the first reported nanozyme and the first FDA-approved transition-metal-based nanomaterial, holds promise for antibacterial therapy but is limited by poor ROS catalytic activity and utilization. Inspired by macrophage-like bacterial capture and insect wing micro/n...
- Biology
ABSTRACT Dual‐targeted strategies addressing both infection and trauma from invasive devices are imperative. Herein, we developed a bionic protein bond constraint strategy to construct multifunctional quaternary ammonium hydrogel coatings (BEAC). Inspired by the secondary bonds s...